테스토스테론 보충 요법(TRT) 시장 보고서 : 제품 유형별, 유효 성분별, 최종사용자별, 지역별(2025-2033년)

The global testosterone replacement therapy market size reached USD 2.03 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.73 Billion by 2033, exhibiting a growth rate (CAGR) of 3.2% during 2025-2033. The rising prevalence of hypogonadism among the masses, continual development of new formulations, delivery methods, and improved treatment protocols, and ongoing improvements in healthcare infrastructure across the globe are some of the major factors propelling the market.

Testosterone replacement therapy (TRT) is a medical treatment designed to address low testosterone levels in individuals, particularly men. Testosterone is a hormone primarily responsible for the development and maintenance of male sexual characteristics and overall well-being. TRT involves the administration of exogenous testosterone to supplement the body's natural production, aiming to restore testosterone levels within the normal range. Low testosterone levels can result in various symptoms, including reduced libido, fatigue, muscle loss, mood changes, and decreased bone density. TRT can alleviate these symptoms and improve the overall quality of life for individuals experiencing testosterone deficiency. The therapy can be administered through various methods, including injections, patches, gels, or pellets implanted under the skin.

The rising prevalence of hypogonadism is driving the global market. Moreover, continual advancements in the formulation and delivery methods, including newer delivery methods, such as transdermal patches, gels, subcutaneous implants, and buccal systems, offer improved convenience and efficacy, enhancing patient compliance and satisfaction is providing a boost to the market. Furthermore, cultural acceptance, reduced stigma, and a broader understanding of the benefits of TRT have contributed to the growth of the market. Also, various pharmaceutical companies are investing in the development of new formulations, delivery methods, and improved treatment protocols, which fuels the growth of the market. Apart from this, the overall growth in healthcare expenditure, driven by factors such as rising healthcare infrastructure, improving access to healthcare services, and increasing disposable income, has catalyzed the expansion of the TRT market.

Testosterone Replacement Therapy Market Trends/Drivers:

Aging Population and the Increasing Prevalence Of Testosterone Deficiency

The aging population is a significant market driver for testosterone replacement therapy (TRT). As men age, their natural testosterone production tends to decline, resulting in symptoms associated with testosterone deficiency. With the global population experiencing a demographic shift towards an older age bracket, there is a growing prevalence of testosterone deficiency. Coupled with this, the increasing awareness of the symptoms and benefits of TRT, is augmenting the demand for testosterone replacement products and services. Furthermore, healthcare providers are witnessing an increase in older patients seeking treatment for low testosterone levels to alleviate symptoms, such as reduced energy, diminished sexual function, and muscle loss, thereby propelling the growth of the TRT market.

Rising Awareness and Diagnosis of Testosterone Deficiency

There has been a notable increase in awareness and diagnosis of testosterone deficiency in recent years. Healthcare professionals are becoming more knowledgeable about the symptoms and effects of low testosterone levels, leading to improved detection and diagnosis. Additionally, educational campaigns and marketing efforts by pharmaceutical companies and healthcare organizations have contributed to raising public awareness about the availability of treatment options, such as TRT. These initiatives emphasize the potential benefits of TRT in addressing the physical and psychological symptoms associated with testosterone deficiency. As a result, more individuals are seeking medical advice and getting diagnosed, leading to a larger patient pool for TRT. This heightened awareness and diagnosis have resulted in an expanded market for testosterone replacement therapies.

Growing Focus on Men's Health and Wellness

There is a growing emphasis on men's health and wellness, encompassing physical, mental, and sexual well-being. Men are becoming more proactive in seeking solutions to age-related issues, including testosterone deficiency. As societal attitudes shift towards destigmatizing men's health concerns, individuals are more open to discussing and seeking treatment for conditions related to testosterone imbalance. This cultural shift, along with increased accessibility to healthcare information through the internet and social media, has contributed to a greater demand for TRT. The market is witnessing a rise in men who are actively pursuing therapies to address testosterone deficiency and improve their overall quality of life. Furthermore, the expanding wellness industry and the integration of holistic approaches in men's healthcare have further fueled the demand for TRT.

Testosterone Replacement Therapy Industry Segmentation:

Breakup by Product Type:

Oral implants

Injections

Patches

Creams/Gels

Gums/Buccal Adhesives

Others

Injections dominate the market

On the basis of product type, injections represent the largest product type segment in the testosterone replacement therapy (TRT) market. Injections are a popular and widely utilized method for delivering testosterone replacement. They offer several advantages, including reliable dosing, immediate effects, and the ability to closely monitor the administration. Injections typically involve intramuscular or subcutaneous delivery, ensuring efficient absorption of testosterone into the bloodstream. This method provides healthcare professionals with greater control over dosage and allows for adjustments based on individual patient needs. Moreover, they offer convenience as they are administered less frequently compared to other forms of TRT, such as transdermal patches or gels. This reduced frequency of administration contributes to better patient compliance. Additionally, injections are preferred in cases where patients require higher testosterone levels or have specific medical conditions that may necessitate precise dosing.

Breakup by Active Ingredients:

Testosterone

Methyl Testosterone

Testosterone Cypionate

Testosterone Undecanoate

Testosterone Enanthate

Testosterone holds the largest share in the market

Testosterone represents the largest segment in the testosterone replacement therapy (TRT) market. Testosterone is the primary hormone responsible for the development and maintenance of male sexual characteristics and overall well-being. In TRT, the goal is to supplement or replace the body's natural testosterone production, and testosterone is the most direct and commonly used active ingredient to achieve this. It is available in various formulations, including injections, transdermal patches, gels, and pellets. Moreover, it provides healthcare providers with the flexibility to tailor treatment regimens to individual patient needs. Additionally, testosterone-based products have been extensively studied and researched, providing a robust foundation of clinical evidence supporting their effectiveness in managing testosterone deficiency. Due to its central role in TRT and its proven efficacy, testosterone remains the dominant active ingredient segment in the TRT market, serving as the cornerstone for addressing testosterone imbalances and improving patients' quality of life.

Breakup by End User:

Hospitals

Homecare

Specialty Clinics

Others

Speciality Clinics hold the largest share in the market

On the basis of end user, specialty clinics represent the largest segment in the testosterone replacement therapy (TRT) market. Specialty clinics are healthcare facilities that focus on specific medical specialties or conditions, including men's health and hormone optimization. These clinics are staffed with specialized healthcare professionals, such as endocrinologists, urologists, and hormone therapy specialists, who possess in-depth knowledge and expertise in diagnosing and treating testosterone deficiency. They offer a dedicated and comprehensive approach to TRT, providing personalized care and tailored treatment plans for patients with low testosterone levels. These clinics often have the necessary resources and equipment to administer various forms of TRT, including injections, patches, gels, and pellets. Moreover, specialty clinics are equipped to conduct thorough evaluations, monitor hormone levels, and adjust treatment regimens as needed to optimize patient outcomes.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest testosterone replacement therapy market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Region-wise, North America exhibits a clear dominance in the testosterone replacement therapy (TRT) market. The well-developed healthcare infrastructure in the region is characterized by advanced medical facilities, specialized clinics, and a strong network of healthcare providers. This infrastructure facilitates the diagnosis, treatment, and monitoring of testosterone deficiency, driving the demand for TRT. Additionally, the region has a high prevalence of testosterone deficiency, which can be attributed to factors such as an aging population, sedentary lifestyles, and increasing awareness of the symptoms and benefits of TRT. Moreover, the region is at the forefront of medical advancements and research in the field of hormone replacement therapies, leading to the availability of a wide range of TRT products and treatment options. Furthermore, robust regulatory frameworks and guidelines ensure the safety and efficacy of TRT in North America, instilling confidence in both healthcare providers and patients.

Competitive Landscape:

Companies are heavily investing in research and development activities to develop innovative TRT products and treatment options. This includes exploring new formulations, delivery systems, and technologies to enhance treatment efficacy, convenience, and patient compliance. Several leading players are conducting clinical trials to gather evidence supporting the safety and efficacy of their TRT products. These trials help validate the therapeutic benefits of their offerings and gain regulatory approvals. Moreover, companies engage in marketing and awareness campaigns to educate healthcare professionals and patients about the symptoms of testosterone deficiency and the benefits of TRT. These campaigns aim to increase awareness, reduce stigma, and drive demand for their products and services. Additionally, companies collaborate with healthcare providers, specialty clinics, and research institutions to expand their market reach, gain access to patient populations, and leverage expertise in specific therapeutic areas.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AbbVie Inc.

Acerus Pharmaceuticals Corporation

Antares Pharma Inc. (Halozyme Therapeutics)

Clarus Therapeutics Inc

Endo International plc

Ferring Pharmaceuticals

Kyowa Kirin Co. Ltd.

Lupin Limited

Pfizer Inc.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)

Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)

Key Questions Answered in This Report:

• How has the global testosterone replacement therapy market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global testosterone replacement therapy market?
• What is the impact of each driver, restraint, and opportunity on the global testosterone replacement therapy market?
• What are the key regional markets?
• Which countries represent the most attractive testosterone replacement therapy market?
• What is the breakup of the market based on the product type?
• Which is the most attractive product type in the testosterone replacement therapy market?
• What is the breakup of the market based on the active ingredients?
• Which is the most attractive active ingredients in the testosterone replacement therapy market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the testosterone replacement therapy market?
• What is the competitive structure of the global testosterone replacement therapy market?
• Who are the key players/companies in the global testosterone replacement therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Testosterone Replacement Therapy Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Oral Implants
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Injections
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Patches
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Creams/Gels
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Gums/Buccal Adhesives
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Active Ingredients

• 7.1 Testosterone
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Methyl Testosterone
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Testosterone Cypionate
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Testosterone Undecanoate
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Testosterone Enanthate
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Homecare
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Specialty Clinics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 AbbVie Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Acerus Pharmaceuticals Corporation
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Antares Pharma Inc. (Halozyme Therapeutics)
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 SWOT Analysis
  • 14.3.4 Clarus Therapeutics Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
  • 14.3.5 Endo International plc
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Ferring Pharmaceuticals
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Kyowa Kirin Co. Ltd.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Lupin Limited
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Pfizer Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Sun Pharmaceutical Industries Ltd.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.